Schwartz Aharon

EDGAR CIK 0001625184

Protalix Biotherapeutics, Inc. - PLX

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
1
$205,884
129,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/10/2025
08/12/2025
Buy
129,000 @ $1.60
 $205,884 303,000 (74.14%) Direct